Business Context and Reporting Period
Company: Daré Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 15, 2018
Reporting Period: Single event date (June 15, 2018)
Business Context: The registrant is an emerging growth company incorporated in Delaware. This filing serves as a Regulation FD disclosure to distribute a corporate presentation regarding the company and its product candidates to investors and analysts.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The filing solely announces the release of a corporate presentation (Exhibit 99.1) dated June 15, 2018.
Guidance, Outlook, and Risks
- Management Commentary: The company intends to use the attached presentation in meetings with investors and securities analysts commencing June 15, 2018.
- Legal Disclaimer: The information contained in the presentation is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liability of that section. It will not be incorporated by reference into other filings unless expressly stated.
- Outlook: Specific forward-looking guidance is contained within the referenced Exhibit 99.1, which is not included in the text of this summary.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for specific details on product candidates and strategic outlook.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm that the presentation materials are not legally "filed" for liability purposes under Section 18 of the Exchange Act.